New Targeted Lung Cancer Drug, Retevmo, So Effective It Gave Musician His Life Back

Updated April 4th, 2021

New Targeted Lung Cancer Drug, Retevmo, So Effective It Gave Musician His Life Back

RET+ lung cancers are aggressive and have a poor prognosis, but new targeted drug selpercatinib (Retevmo) benefits more than 90% of patients who have this type of cancer.

NOW
PLAYING
Student Battles Stage III Synovial Sarcoma Afer Assuming Lump Is a Clot
NOW
PLAYING
Chantix Recall Grows As FDA Tests Show Excessive Levels of Carcinogen
NOW
PLAYING
COVID Booster Shots Approved for Cancer Patients, Other Immunocompromised Americans; No Prescription, ID is Required
NOW
PLAYING
'Bachelorette' Star Greg Grippo Says Not Fully Coping With Losing His Father To Cancer Might Have Caused The Downfall Of His Relationship With Katie
NOW
PLAYING
Brave Woman Battling Late-Stage Endometrial Cancer Gains Huge Support In Asking AstraZeneca For Potentially Life-Saving Therapy: "It’s Given Me Strength"
NOW
PLAYING
It’s World Lung Cancer Day: How Have Treatment Options Changed for Lung Cancer Patients?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.